Serum and tissue tumour markers in seminomas.

Autor: Ford TF, Butcher DN, Samuell CT, Masters JR, Parkinson MC, Oliver RT
Jazyk: angličtina
Zdroj: British journal of urology [Br J Urol] 1985 Dec; Vol. 57 (6), pp. 750-4.
DOI: 10.1111/j.1464-410x.1985.tb07047.x
Abstrakt: The serum expression of the tumour markers hydroxybutyric dehydrogenase (HBD), beta human chorionic gonadotrophin (beta HCG), alphafetoprotein (alpha FP) and placental alkaline phosphatase (PLAP) has been assessed in a consecutive series of 50 patients with pure seminoma. In pre-orchiectomy sera from 15 patients with stage I disease, HBD was elevated in 5, beta HCG in 3, alpha FP in 1 and PLAP in 1 (of 3 only). In 27 patients with stage 2 or 3 disease, prior to chemotherapy, serum HBD was elevated in 19, beta HCG in 11, alpha FP in 2 and PLAP in 10 (of 18). The presence of beta HCG was investigated immunocytochemically in primary tumour tissue from 39 patients. It was demonstrated in 6 of 21 tumours from patients with stage I disease and 5 of 18 with stage 2 or 3 disease.
Databáze: MEDLINE